243 results on '"Lechtzin N"'
Search Results
2. 498 The cystic fibrosis Wellness Program to treat fatigue: Pilot and feasibility study results
3. 681 Collecting and addressing social determinants of health information in an adult cystic fibrosis clinic through quality improvement
4. 627 Prevalence and predictors of high cardiovascular risk in adults with cystic fibrosis
5. 717 Provider practices in management of pulmonary exacerbations in the era of highly effective modulator therapy
6. 356 Establishment of primary sweat gland cultures suitable for CFTR functional and RNA analysis
7. 582 Cholesterol levels increase on elexacaftor-tezacaftor-ivacaftor therapy but remain within acceptable ranges
8. WS05.06 Phase 1/2a randomized, double-blind, placebo-controlled study: safety, Pk, and Efficacy outcome measures of inhaled Gallium Citrate (AR-501) in P Aeruginosa infected Cystic Fibrosis patients
9. P185 Prospective randomized observational study validating biomarkers for association with future pulmonary exacerbations in people with cystic fibrosis
10. Quantitative CT Analysis With Functional Respiratory Imaging Detects Objective Pulmonary Abnormalities in Subject With History of Exposure to Military Burn Pits
11. 319 Fatigue and poor sleep quality prevalent even in setting of elexacaftor/tezacaftor/ivacaftor
12. 280 Patient priorities for addressing aging related topics during cystic fibrosis clinic
13. 507 Phase 1/2a randomized, double-blind, placebo-controlled study: Safety, pharmacokinetics, and efficacy outcome measures of inhaled gallium citrate (AR-501) in people with cystic fibrosis
14. Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type
15. P042 The effect of elexacaftor/tezacaftor/ivacaftor on non-pulmonary symptoms in adults with cystic fibrosis
16. High-Quality CMV-Specific CD4+ Memory Is Enriched in the Lung Allograft and Is Associated With Mucosal Viral Control
17. 291: Impact of highly effective modulator therapy on patient-reported outcomes in CF
18. 544: Safety and tolerability of single and repeat doses of MRT5005, an inhaled CFTR mRNA replacement therapy, in adult CF patients
19. 35: Female sex is associated with increased pulmonary exacerbations in people with cystic fibrosis
20. P184 Sex differences in annual pulmonary exacerbations in people with cystic fibrosis
21. A Phase 2, Double-Blind, randomized, Dose-Ranging trial Of Reldesemtiv in patients with ALS
22. Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
23. PHASE 1 PHARMACOKINETIC AND SAFETY STUDY OF INTRAVENOUS GANITE™ (GALLIUM NITRATE) IN CF: 226
24. DESIGN AND PLANNING OF THE EARLY INTERVENTION IN CYSTIC FIBROSIS EXACERBATION RANDOMIZED TRIAL: 368
25. Low Observed Rates of Macrolide-Resistant Mycobacterium Avium Complex Despite Chronic Azithromycin Exposure in Cystic Fibrosis
26. Tobramycin Exposure and Amikacin Susceptibility in Mycobacterium Abscessus in Cystic Fibrosis
27. Causes of death amongst French patients with amyotrophic lateral sclerosis: is guideline recommended care getting lost in translation?
28. PAIN IS A COMMON, UNDER-RECOGNIZED PROBLEM AFFECTING QUALITY OF LIFE, MOOD, AND SLEEP IN ADULTS WITH CF: 672⋆
29. THE EFFECT OF THE LUNG ALLOCATION SCORE ON EARLY OUTCOMES IN LUNG TRANSPLANTATION AMONG INDIVIDUALS WITH CYSTIC FIBROSIS: 540⋆
30. Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis
31. VERY HIGH-DOSE ERGOCALCIFEROL IS EFFECTIVE FOR CORRECTING VITAMIN D DEFICIENCY IN ADULTS WITH CYSTIC FIBROSIS: 513★
32. THE JOHNS HOPKINS ADULT CYSTIC FIBROSIS PROGRAM QUALITY IMPROVEMENT PROJECT: 447*
33. Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis
34. WS01-3 IV gallium nitrate demonstrates biological activity for chronic Pseudomonas aeruginosa infection in cystic fibrosis
35. WS05-5 Use of opioids for pain management in individuals with cystic fibrosis
36. Do Known Sources of Indoor Air Pollution Affect Lung Function in Cystic Fibrosis?
37. Maternal Outcomes in Pregnant Women with Cystic Fibrosis
38. EPS6.1 A feasibility study of remote monitoring of airway clearance vest use and home spirometry in adults with cystic fibrosis
39. 86 A novel, highly-sensitive ELISA assay can detect Pseudomonas aeruginosa virulence factors in CF sputum
40. (218) The lived experience of pain in adolescents diagnosed with cystic fibrosis
41. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trial
42. Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes.
43. 304 Impact of Health-Related Quality of Life on Survival in Pulmonary Arterial Hypertension
44. Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
45. 186: CD8+ pp65-Specific T Cell Responses and T-Bet Levels Predict Relapsing Viremia Following Primary CMV Infection in Lung Transplant Recipients
46. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
47. Assessment of Myocardial Fibrosis in Pulmonary Arterial Hypertension Using Cardiac MRI Delayed Contrast Enhancement.
48. Differences in Health-Related Quality of Life in Various Forms of Pulmonary Hypertension.
49. Survival of Pulmonary Arterial Hypertension Related to Systemic Sclerosis: A Single Center Longitudinal Study.
50. TAPSE Predicts Invasive Hemodynamic Markers of Right Ventricular Function in PAH.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.